ArticleFrontiers in cell and developmental biology2023

Identification and validation of a small molecule targeting ROR1 for the treatment of triple negative breast cancer.

Shradheya R R Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.